Colchicine Prevents Disease Progression in Viral Myocarditis Via Modulating the NLRP3 Inflammasome in the Cardiosplenic Axis

Kathleen Pappritz(Berlin-Brandenburger Centrum für Regenerative Therapien), Sophie Van Linthout(Deutsches Herzzentrum der Charité), Muhammad El‐Shafeey(Justus-Liebig-Universität Gießen), Ahmed Elsanhoury(Berlin-Brandenburger Centrum für Regenerative Therapien), Frank Spillmann(Deutsches Herzzentrum der Charité), Alessio Alogna(Deutsches Herzzentrum der Charité), Henry Fechner(Technische Universität Berlin), Carsten Tschöpe(Deutsches Herzzentrum der Charité), Rainer Schulz(Justus-Liebig-Universität Gießen), Jie Lin(Berlin-Brandenburger Centrum für Regenerative Therapien), Uwe Kühl(German Centre for Cardiovascular Research)
ESC Heart Failure
February 17, 2022
10.1002/ehf2.13845
Cited by 77

Related Papers

Type 2 Diabetes Mellitus and Heart Failure: A Position Statement from the Heart Failure Association of the European Society of Cardiology
|European Journal of Heart Failure|2018|716
Inflammation – Cause or Consequence of Heart Failure or Both?
|Current Heart Failure Reports|2017|457
High-Density Lipoproteins and Their Constituent, Sphingosine-1-Phosphate, Directly Protect the Heart Against Ischemia/Reperfusion Injury In Vivo via the S1P <sub>3</sub> Lysophospholipid Receptor
|Circulation|2006|413
Right Heart Dysfunction and Failure in Heart Failure with Preserved Ejection Fraction: Mechanisms and Management. Position Statement on Behalf of the Heart Failure Association of the European Society of Cardiology
|European Journal of Heart Failure|2017|380
ATP Release From Activated Neutrophils Occurs via Connexin 43 and Modulates Adenosine-Dependent Endothelial Cell Function
|Circulation Research|2006|356